Technology | August 09, 2013

IBA Launches Compass Two-in-One Radiation Therapy Plan Verification System

Compass provides needed flexibility for optimal QA efficiency enabling measurement as well as full 3-D calculation-based independent treatment plan verification

August 9, 2013 — IBA (Ion Beam Applications S.A) has launched its Compass 3.0 plan verification system. Compass, the first patient anatomy-centric and solution for advanced intensity-modulated radiotherapy (IMRT) and rotational plan verification now provides a new two-in-one solution: calculation-based, full 3-D independent treatment plan system (TPS) verification and measurement-based quality assurance (QA) for the complete treatment chain, including linear accelerators.

Compass offers full workflow flexibility, allowing physicists and dosimetrists to choose the most efficient QA for any clinical need.

The new Compass also provides crucial calculation time saving and therefore much faster QA workflows. Dose calculations of 7 beam IMRT plans are done in just one minute, and more sophisticated 1 arc volumetric modulated arc therapy (VMAT) plans in just over two minutes.

With its powerful collapsed cone algorithm for independent dose calculations, Compass allows TPS-class dose calculations on real patient computed tomography (CT) as well as real patient CT-based DVH, and 3-D Gamma.

Independent beam modeling of individual linacs enables flexibility in precisely modeling as many machines as needed for highly accurate plan verifications. Physicists can measure and compare real linac delivery versus TPS-planned delivery as well as analyze the effect of segment errors on the total treatment accuracy. Plan verification is a step in radiation therapy to ensure treatment accuracy and patient dose safety.

For more information:

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init